Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This study will help researchers test the safety of hypofractionated dose of radiotherapy
(HySBst) at different dose levels before or after chemo-radiation for Non Small Cell Lung
Cancer.